Taysha Gene Therapies (TSHA) PT Raised to $8 at Citizens on Competitive Advantage
Tweet Send to a Friend
Citizens analyst Silvan Tuerkcan raised the price target on Taysha Gene Therapies (NASDAQ: TSHA) to $8.00 (from $6.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
